Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Director · Chief Executive Officer · 10% owner | August 25, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date August 25, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT | 0 |
Reported balance
After 2026-08-25 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2026-08-25 · Gift · Disposed 463,289 · Balance 0 F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT | 463,289 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 463,289 F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Legacy 2021 Trust | 103,406 |
Reported balance
After 2026-08-27 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2026-08-27 · Other · Disposed 977,566 · Balance 103,406 F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes. |
| Class A Common StockSEC Table I · non-derivative | Direct | 1,033,177 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,033,177 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 | 573,202 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 573,202 F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2025 GRAT dated 5-27-2025 | 42,993 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 42,993 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family Community Property Trust | 470,457 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 470,457 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT 2 dated 9/7/2022 | 791,117 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 791,117 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family Heritage Trust UAD 8-10-2021 | 2,214,769 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 2,214,769 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family 2021 Trust | 3,004,071 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · Balance 3,004,071 |
Filing footnotes · ownership attribution and instrument terms
F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.
F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.
F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2021 Filed Aug 7, 2021 01:00 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 46,238 | $11.50 | $531,737.00 |
DisclosureSEC source: 0000899243-21-031998 · doc4.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Atomic Labs II, L.P. Disclosed balance after: 8,314,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Atomic Labs II, L.P. exercised warrants to purchase shares of the Issuer's Class A Common Stock. The warrants were exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, Atomic Labs II, L.P. received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrants, the withholding of shares of Class A Common Stock in the cashless exercise and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F3 · ownership.nature: Mr. Dudum is a managing member of Atomic GP II, LLC, the general partner and manager of Atomic Labs II, L.P. Mr. Dudum may be deemed the beneficial owner of the shares held by Atomic Labs II, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. Read SEC document |
| July 28, 2021 Filed Jul 31, 2021 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionWarrant (right to buy) · Derivative | 16,028 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000899243-21-030878 · doc4.xml · derivative · entry 8 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trustee of the AD GRAT dated 8/31/20 Disclosed balance after: 0 Underlying: Class A Common Stock · 16,028 shares Expires 2026-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2021 Filed Jul 31, 2021 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionWarrant (right to buy) · Derivative | 94,582 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000899243-21-030878 · doc4.xml · derivative · entry 7 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 0 Underlying: Class A Common Stock · 94,582 shares Expires 2026-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2021 Filed Jul 31, 2021 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 11,749 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-030878 · doc4.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trustee of the AD GRAT dated 8/31/20 Disclosed balance after: 2,870,509 F2 · kind: Represents shares of Class A Common Stock withheld in connection with the cashless exercise. F1 · price: The Reporting Person exercised a warrant to purchase shares of the Issuer's Class A Common Stock. The warrant was exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Reporting Person received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrant, the withholding of shares of Class A Common Stock in the cashless exercise and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 28, 2021 Filed Jul 31, 2021 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 69,329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-030878 · doc4.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 8,232,404 F2 · kind: Represents shares of Class A Common Stock withheld in connection with the cashless exercise. F1 · price: The Reporting Person exercised a warrant to purchase shares of the Issuer's Class A Common Stock. The warrant was exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Reporting Person received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrant, the withholding of shares of Class A Common Stock in the cashless exercise and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 28, 2021 Filed Jul 31, 2021 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 16,028 | $11.50 | $184,322.00 |
DisclosureSEC source: 0000899243-21-030878 · doc4.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trustee of the AD GRAT dated 8/31/20 Disclosed balance after: 2,882,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Reporting Person exercised a warrant to purchase shares of the Issuer's Class A Common Stock. The warrant was exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Reporting Person received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrant, the withholding of shares of Class A Common Stock in the cashless exercise and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 28, 2021 Filed Jul 31, 2021 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 94,582 | $11.50 | $1,087,693.00 |
DisclosureSEC source: 0000899243-21-030878 · doc4.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 8,301,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Reporting Person exercised a warrant to purchase shares of the Issuer's Class A Common Stock. The warrant was exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Reporting Person received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrant, the withholding of shares of Class A Common Stock in the cashless exercise and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 18, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 22,142 | $12.07 | $267,253.94 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,853 F2 · kind: The sales reported represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the previously reported vesting and settlement of RSUs. These sales are mandated by the issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 18, 2021 Filed Jul 24, 2021 01:23 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 22,142 | $12.07 | $267,253.94 |
DisclosureSEC source: 0000899243-21-029812 · doc4a.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,853 F2 · kind: On July 22, 2021, the reporting person filed a Form 4 which inadvertently reported that 22,142 shares of Class A Common Stock were sold to cover tax withholding obligations of the issuer with respect to the vesting of the restricted stock units ("RSUs"). This Form 4/A is being filed to amend this transaction line item and reflect that such shares of Class A Common Stock were withheld by the issuer to cover such tax withholding obligations. Read SEC document |
| June 16, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 1,789 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · derivative · entry 15 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,835 Underlying: Class A Common Stock · 1,789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on June 16, 2021. F7 · derivative.exercise_date: The RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of vesting on each Company Quarterly Vesting Date, subject to the individual's continuous service. F7 · derivative.expiration_date: The RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of vesting on each Company Quarterly Vesting Date, subject to the individual's continuous service. Read SEC document |
| June 16, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · derivative · entry 14 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,336 Underlying: Class A Common Stock · 18,289 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on June 16, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| June 16, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 7,329 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · derivative · entry 13 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,950 Underlying: Class A Common Stock · 7,329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on June 16, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| June 16, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 106 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · derivative · entry 12 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,601 Underlying: Class A Common Stock · 106 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on June 16, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| June 16, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 3,575 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · derivative · entry 11 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,630 Underlying: Class A Common Stock · 3,575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on June 16, 2021. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| June 16, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 198 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · derivative · entry 10 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,172 Underlying: Class A Common Stock · 198 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on June 16, 2021. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| June 16, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,923 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · derivative · entry 9 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,154 Underlying: Class A Common Stock · 9,923 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on June 16, 2021. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| June 16, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 41,209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on June 16, 2021. Read SEC document |
| May 24, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 196,553 | $10.56 | $2,075,599.68 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,786 F2 · kind: The sales reported represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the previously reported vesting and settlement of RSUs. These sales are mandated by the issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 24, 2021 Filed Jul 24, 2021 01:23 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 196,553 | $10.56 | $2,075,599.68 |
DisclosureSEC source: 0000899243-21-029812 · doc4a.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,786 F1 · kind: On July 22, 2021, the reporting person filed a Form 4 which inadvertently reported that 196,553 shares of Class A Common Stock were sold to cover tax withholding obligations of the issuer with respect to the vesting of the restricted stock units ("RSUs"). This Form 4/A is being filed to amend this transaction line item and reflect that such shares of Class A Common Stock were withheld by the issuer to cover such tax withholding obligations. Read SEC document |
| May 20, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 6,319 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · derivative · entry 8 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,319 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on May 20, 2021. F5 · derivative.exercise_date: The RSUs fully vested upon grant. F5 · derivative.expiration_date: The RSUs fully vested upon grant. Read SEC document |
| May 20, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 317,539 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · derivative · entry 7 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 317,539 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on May 20, 2021. F5 · derivative.exercise_date: The RSUs fully vested upon grant. F5 · derivative.expiration_date: The RSUs fully vested upon grant. Read SEC document |
| May 20, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 789 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · derivative · entry 6 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,370 Underlying: Class A Common Stock · 789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on May 20, 2021. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| May 20, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 39,692 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · derivative · entry 5 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,077 Underlying: Class A Common Stock · 39,692 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on May 20, 2021. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| May 20, 2021 Filed Jul 23, 2021 00:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 364,339 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-029551 · doc4.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person is hereby disclosing a delinquent Form 4. The Reporting Person's Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on May 20, 2021. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 117,279 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014234 · doc4.xml · derivative · entry 9 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,279 Underlying: Class A Common Stock · 117,279 shares Expires not disclosed F4 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 1,707 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014234 · doc4.xml · derivative · entry 8 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,707 Underlying: Class A Common Stock · 1,707 shares Expires not disclosed F4 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 57,205 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014234 · doc4.xml · derivative · entry 7 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,205 Underlying: Class A Common Stock · 57,205 shares Expires not disclosed F4 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 3,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014234 · doc4.xml · derivative · entry 6 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,159 Underlying: Class A Common Stock · 3,159 shares Expires not disclosed F3 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vest when (i) the issuer is acquired and the per share consideration is equal to at least $38.31 per share (subject to appropriate adjustment for stock splits and otherwise, the "Threshold Amount") or (ii) the per share closing trading price of the issuer's Class A Common Stock is at least equal to the Threshold Amount (the date on which such closing trading price is achieved, the "Achievement Date"), provided that the Reporting Person remains in continuous service as chief executive officer or a director through such acquisition or the Achievement Date, as applicable. F3 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vest when (i) the issuer is acquired and the per share consideration is equal to at least $38.31 per share (subject to appropriate adjustment for stock splits and otherwise, the "Threshold Amount") or (ii) the per share closing trading price of the issuer's Class A Common Stock is at least equal to the Threshold Amount (the date on which such closing trading price is achieved, the "Achievement Date"), provided that the Reporting Person remains in continuous service as chief executive officer or a director through such acquisition or the Achievement Date, as applicable. F3 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vest when (i) the issuer is acquired and the per share consideration is equal to at least $38.31 per share (subject to appropriate adjustment for stock splits and otherwise, the "Threshold Amount") or (ii) the per share closing trading price of the issuer's Class A Common Stock is at least equal to the Threshold Amount (the date on which such closing trading price is achieved, the "Achievement Date"), provided that the Reporting Person remains in continuous service as chief executive officer or a director through such acquisition or the Achievement Date, as applicable. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 158,769 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014234 · doc4.xml · derivative · entry 5 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,769 Underlying: Class A Common Stock · 158,769 shares Expires not disclosed F3 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vest when (i) the issuer is acquired and the per share consideration is equal to at least $38.31 per share (subject to appropriate adjustment for stock splits and otherwise, the "Threshold Amount") or (ii) the per share closing trading price of the issuer's Class A Common Stock is at least equal to the Threshold Amount (the date on which such closing trading price is achieved, the "Achievement Date"), provided that the Reporting Person remains in continuous service as chief executive officer or a director through such acquisition or the Achievement Date, as applicable. F3 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vest when (i) the issuer is acquired and the per share consideration is equal to at least $38.31 per share (subject to appropriate adjustment for stock splits and otherwise, the "Threshold Amount") or (ii) the per share closing trading price of the issuer's Class A Common Stock is at least equal to the Threshold Amount (the date on which such closing trading price is achieved, the "Achievement Date"), provided that the Reporting Person remains in continuous service as chief executive officer or a director through such acquisition or the Achievement Date, as applicable. F3 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vest when (i) the issuer is acquired and the per share consideration is equal to at least $38.31 per share (subject to appropriate adjustment for stock splits and otherwise, the "Threshold Amount") or (ii) the per share closing trading price of the issuer's Class A Common Stock is at least equal to the Threshold Amount (the date on which such closing trading price is achieved, the "Achievement Date"), provided that the Reporting Person remains in continuous service as chief executive officer or a director through such acquisition or the Achievement Date, as applicable. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 6,319 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014234 · doc4.xml · derivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,319 Underlying: Class A Common Stock · 6,319 shares Expires not disclosed F2 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vested upon grant. F2 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vested upon grant. F2 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vested upon grant. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 317,539 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014234 · doc4.xml · derivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,539 Underlying: Class A Common Stock · 317,539 shares Expires not disclosed F2 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vested upon grant. F2 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vested upon grant. F2 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vested upon grant. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 3,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014234 · doc4.xml · derivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,159 Underlying: Class A Common Stock · 3,159 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 158,769 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014234 · doc4.xml · derivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,769 Underlying: Class A Common Stock · 158,769 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantWarrant (right to buy) · Derivative | 46,238 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 13 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held By Atomic Labs II, L.P. Disclosed balance after: 46,238 Underlying: Class A Common Stock · 46,238 shares Expires 2026-01-20 F14 · derivative.exercise_date: In connection with the Merger, the Reporting Person received additional New Hims warrants in exchange for Class A Common Stock of Hims, Inc. F15 · ownership.nature: Mr. Dudum is a managing member of Atomic GP II, LLC, the general partner and manager of Atomic Labs II, L.P. Mr. Dudum may be deemed the beneficial owner of the shares held by Atomic Labs II, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantWarrant (right to buy) · Derivative | 16,028 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 12 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trustee of the AD GRAT dated 8/31/20 Disclosed balance after: 16,028 Underlying: Class A Common Stock · 16,028 shares Expires 2026-01-20 F14 · derivative.exercise_date: In connection with the Merger, the Reporting Person received additional New Hims warrants in exchange for Class A Common Stock of Hims, Inc. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantWarrant (right to buy) · Derivative | 94,582 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 11 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 94,582 Underlying: Class A Common Stock · 94,582 shares Expires 2026-01-20 F14 · derivative.exercise_date: In connection with the Merger, the Reporting Person received additional New Hims warrants in exchange for Class A Common Stock of Hims, Inc. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 28,624 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 10 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,624 Underlying: Class A Common Stock · 28,624 shares Expires not disclosed F12 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out Shares (the "Earn Out RSUs"). F13 · derivative.exercise_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 11 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out Conditions. If the RSU Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited. F13 · derivative.expiration_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 11 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out Conditions. If the RSU Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 292,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 9 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,625 Underlying: Class A Common Stock · 292,625 shares Expires not disclosed F10 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs"). F11 · derivative.exercise_date: The New Hims RSUs were received in exchange for 646,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service. The New Hims RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027. F11 · derivative.expiration_date: The New Hims RSUs were received in exchange for 646,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service. The New Hims RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantStock Option (right to buy) · Derivative | 584,797 | $0.00 Strike: $9.41 | $0.00 |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 8 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 584,797 Underlying: Class A Common Stock · 584,797 shares Expires 2020-12-23 F9 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 1,291,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning with December 16, 2020. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantStock Option (right to buy) · Derivative | 1,623,069 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 7 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,623,069 Underlying: Class A Common Stock · 1,623,069 shares Expires 2030-06-16 F8 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 100% of the shares subject to the option vest when (i) New Hims is acquired and the per share consideration is equal to at least the Threshold Amount or (ii) the per share closing trading price of New Hims' Class A Common Stock on a public stock exchange is at least equal to the Threshold Amount, provided that the Reporting Person remains in continuous service as CEO or a director of New Hims through the acquisition or Achievement Date, as applicable. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantStock Option (right to buy) · Derivative | 3,246,139 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 6 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,246,139 Underlying: Class A Common Stock · 3,246,139 shares Expires 2030-06-16 F7 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 7,166,182 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 100% of the shares subject to the Stock Option vest when (i) New Hims is acquired and the per share consideration is equal to at least $17.35 per share (subject to appropriate adjustment for the Merger, stock splits and otherwise, the "Threshold Amount") or (ii) the per share closing trading price of New Hims' Class A Common Stock on a public stock exchange is at least equal to the Threshold Amount (the date on which such closing trading price is achieved, the "Achievement Date"), provided that the Reporting Person remains in continuous service as CEO or a director through the acquisition or Achievement Date, as applicable. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantStock Option (right to buy) · Derivative | 1,623,069 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 5 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,623,069 Underlying: Class A Common Stock · 1,623,069 shares Expires 2030-06-16 F6 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantClass V Common Stock · Derivative | 8,377,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 8,377,623 Underlying: Class A Common Stock · 8,377,623 shares Expires not disclosed F5 · derivative.exercise_price: In connection with the Merger, the Reporting Person received shares of New Hims Class V Common Stock in exchange for shares of Class V Common Stock of Hims, Inc. As specified in that New Hims Certificate of Incorporation, dated as of January 20, 2021 (the "Charter"), New Hims Class V Common Stock is convertible into an equal number of fully paid and nonassessable shares of New Hims Class A Common Stock upon certain events. F5 · derivative.exercise_date: In connection with the Merger, the Reporting Person received shares of New Hims Class V Common Stock in exchange for shares of Class V Common Stock of Hims, Inc. As specified in that New Hims Certificate of Incorporation, dated as of January 20, 2021 (the "Charter"), New Hims Class V Common Stock is convertible into an equal number of fully paid and nonassessable shares of New Hims Class A Common Stock upon certain events. F5 · derivative.expiration_date: In connection with the Merger, the Reporting Person received shares of New Hims Class V Common Stock in exchange for shares of Class V Common Stock of Hims, Inc. As specified in that New Hims Certificate of Incorporation, dated as of January 20, 2021 (the "Charter"), New Hims Class V Common Stock is convertible into an equal number of fully paid and nonassessable shares of New Hims Class A Common Stock upon certain events. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantClass A Common Stock | 8,268,565 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Atomic Labs II, L.P. Disclosed balance after: 8,268,565 F4 · price: In connection with the Merger, the Reporting Person received (i) 7,531,800 shares of Class A Common Stock of New Hims and (ii) 736,765 Earn Out Shares in exchange for 16,627,218 shares of Class A Common Stock of Hims, Inc. If the Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out Shares will be automatically forfeited. F15 · ownership.nature: Mr. Dudum is a managing member of Atomic GP II, LLC, the general partner and manager of Atomic Labs II, L.P. Mr. Dudum may be deemed the beneficial owner of the shares held by Atomic Labs II, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantClass A Common Stock | 2,866,230 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by AD GRAT dated 8/31/20 Disclosed balance after: 2,866,230 F3 · price: In connection with the Merger, the Reporting Person received (i) 2,610,837 shares of Class A Common Stock of New Hims and (ii) 255,393 Earn Out Shares in exchange for 5,763,689 shares of Class A Common Stock of Hims, Inc. If the Earn Out Conditions are not met during the Earn Out Period, then the unvested Earn Out Shares will be automatically forfeited. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantClass A Common Stock | 8,207,151 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-003094 · doc4.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 8,207,151 F1 · price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 6,700,108 shares of Class A Common Stock of New Hims and (ii) 1,507,043 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 15,516,292 shares of Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited. F2 · price: (Continued form footnote 1) On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.